Codes / ICD10CM / L01.1

L01.1 Impetiginization of other dermatoses

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Impetiginization of other dermatoses

Summary

Impetiginization of other dermatoses refers to the secondary bacterial infection of pre-existing skin conditions, leading to impetigo-like changes. This occurs when bacteria, typically Staphylococcus aureus or Streptococcus pyogenes, colonize or infect an already compromised skin surface, resulting in characteristic crusting, oozing, or honey-colored lesions. The condition often arises in areas with underlying dermatoses such as eczema, psoriasis, or insect bites.

Causes

Impetiginization is caused by bacterial infection, most commonly Staphylococcus aureus or Streptococcus pyogenes. These bacteria invade the skin through breaks in the epidermal barrier, such as those created by pre-existing dermatoses, minor trauma, or scratching. The infection may spread locally or become more extensive if left untreated.

Risk Factors

  • Pre-existing skin conditions (e.g., eczema, psoriasis, dermatitis).
  • Skin trauma or scratching that disrupts the skin barrier.
  • Poor hygiene or exposure to contaminated environments.
  • Weakened immune system or chronic skin inflammation.

Symptoms

  • Crusting, oozing, or honey-colored lesions on affected skin.
  • Redness, swelling, or tenderness in the infected area.
  • Itching or discomfort, often exacerbated by scratching.
  • Possible mild fever or lymph node swelling in severe cases.

Diagnosis

A healthcare professional diagnoses impetiginization through a physical examination of the skin, focusing on the appearance of lesions and underlying dermatoses. A bacterial culture or skin swab may be taken to identify the causative organism and guide targeted treatment. Clinical history of pre-existing skin conditions is also considered.

Treatment Options

  • Topical Antibiotics: Mupirocin or fusidic acid cream for localized infections.
  • Oral Antibiotics: Prescribed for extensive or severe cases to eliminate bacterial infection.
  • Underlying Dermatoses Management: Treating the primary skin condition to prevent recurrence.
  • Hygiene Measures: Keeping the affected area clean and avoiding scratching to reduce spread.

Prognosis and Follow-Up

With appropriate treatment, impetiginization typically resolves within 1-2 weeks. Follow-up may be recommended to monitor healing and address any underlying dermatoses. Recurrence is possible if the primary skin condition is not managed effectively.

Complications

  • Spread of infection to other areas or individuals.
  • Scarring or post-inflammatory hyperpigmentation.
  • Rarely, deeper skin infections (e.g., cellulitis) or systemic involvement.

Lifestyle & Prevention

  • Maintain good skin hygiene and avoid scratching.
  • Treat underlying dermatoses promptly to reduce infection risk.
  • Keep affected areas covered to prevent spread in close-contact settings.
  • Use moisturizers to support skin barrier function.

When to Seek Professional Help

Seek medical attention if lesions worsen, spread, or fail to improve with home care. Consult a healthcare provider for persistent symptoms, signs of systemic infection (e.g., fever), or if underlying dermatoses require management.

Tips for Medical Coders

Document the underlying dermatosis and confirm the presence of impetigo-like changes (crusting, oozing) to support the diagnosis. Ensure clinical notes specify the affected skin areas and any treatment provided. Code L01.1 is appropriate when impetiginization is secondary to another dermatosis, not a primary impetigo infection.

Book a walkthrough

L01.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.